Our mission
Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.

Our vision
Create transformative genetic medicines for diseases with high prevalence.

Meet our team

Read More >
Ram Aiyar, Ph.D., MBA
Chief Executive Officer & President

Read More >
Kemi Olugemo, M.D., FAAN
Chief Medical Officer

Read More >
Vineet Agarwal, MBA
Chief Financial Officer

Read More >
Todd Chappell, MBA
Chief Operating Officer

Read More >
Jeffrey M. Cerio, Pharm.D., J.D.
SVP, General Counsel

Read More >
Stephanie Engels
SVP, People and Culture

Read More >
Venkat Krishnamurthy, Ph.D.
SVP, Head of Platform